Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma—an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trialStefan Dietzsch, Rolf‐Dieter Kortmann, Annett Braesigk et al.|Strahlentherapie und Onkologie|2021Cited by 12
Pineal anlage tumor: clinical and diagnostic features, and rationales for treatmentDenise Obrecht, Stefan Rutkowski, Elke Pfaff et al.|Journal of Neuro-Oncology|2024Cited by 5
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Stefan Rutkowski, Martin Mynarek et al.|Journal of Neuro-Oncology|2022Cited by 5
Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategiesMarthe Sönksen, Stefan Rutkowski, Denise Obrecht et al.|Neuro-Oncology|2024Cited by 2
Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatmentDenise Obrecht, Stefan Rutkowski, Lena Schömig et al.|Neuro-Oncology|2024Cited by 1